Strata Critical Medical (SRTA) Competitors

$5.41 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$5.33 -0.08 (-1.55%)

As of 07/2/2026 07:27 PM Eastern

SRTA vs. ULCC, LIND, GEL, CMRE, and FLNG

Should you buy Strata Critical Medical stock or one of its competitors? MarketBeat compares Strata Critical Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Critical Medical include Frontier Group (ULCC), Lindblad Expeditions (LIND), Genesis Energy (GEL), Costamare (CMRE), and Flex LNG (FLNG). These companies are all part of the "transportation" industry.

How does Strata Critical Medical compare to Frontier Group?

Strata Critical Medical (NASDAQ:SRTA) and Frontier Group (NASDAQ:ULCC) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Strata Critical Medical has a net margin of 20.56% compared to Frontier Group's net margin of -9.62%. Strata Critical Medical's return on equity of -4.06% beat Frontier Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	20.56%	-4.06%	-3.49%
Frontier Group	-9.62%	-39.20%	-2.36%

In the previous week, Frontier Group had 3 more articles in the media than Strata Critical Medical. MarketBeat recorded 3 mentions for Frontier Group and 0 mentions for Strata Critical Medical. Frontier Group's average media sentiment score of 0.93 beat Strata Critical Medical's score of -0.05 indicating that Frontier Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
Frontier Group	Positive

Strata Critical Medical has higher earnings, but lower revenue than Frontier Group. Strata Critical Medical is trading at a lower price-to-earnings ratio than Frontier Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.37	$41.35M	-$0.08	N/A
Frontier Group	$3.72B	0.47	-$137M	-$1.60	N/A

Strata Critical Medical has a beta of 2.22, suggesting that its stock price is 122% more volatile than the broader market. Comparatively, Frontier Group has a beta of 2.56, suggesting that its stock price is 156% more volatile than the broader market.

47.4% of Strata Critical Medical shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Comparatively, 48.0% of Frontier Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Strata Critical Medical currently has a consensus target price of $8.00, suggesting a potential upside of 47.87%. Frontier Group has a consensus target price of $6.50, suggesting a potential downside of 14.25%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Strata Critical Medical is more favorable than Frontier Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Frontier Group	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

Summary

Strata Critical Medical beats Frontier Group on 10 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Lindblad Expeditions?

Lindblad Expeditions (NASDAQ:LIND) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

75.9% of Lindblad Expeditions shares are held by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are held by institutional investors. 26.1% of Lindblad Expeditions shares are held by company insiders. Comparatively, 15.5% of Strata Critical Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Strata Critical Medical has lower revenue, but higher earnings than Lindblad Expeditions. Strata Critical Medical is trading at a lower price-to-earnings ratio than Lindblad Expeditions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lindblad Expeditions	$799.31M	2.15	-$29.72M	-$0.54	N/A
Strata Critical Medical	$197.14M	2.37	$41.35M	-$0.08	N/A

Strata Critical Medical has a net margin of 20.56% compared to Lindblad Expeditions' net margin of -2.86%. Lindblad Expeditions' return on equity of 0.00% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lindblad Expeditions	-2.86%	N/A	-0.44%
Strata Critical Medical	20.56%	-4.06%	-3.49%

In the previous week, Lindblad Expeditions had 7 more articles in the media than Strata Critical Medical. MarketBeat recorded 7 mentions for Lindblad Expeditions and 0 mentions for Strata Critical Medical. Lindblad Expeditions' average media sentiment score of -0.04 beat Strata Critical Medical's score of -0.05 indicating that Lindblad Expeditions is being referred to more favorably in the media.

Company	Overall Sentiment
Lindblad Expeditions	Neutral
Strata Critical Medical	Neutral

Lindblad Expeditions currently has a consensus price target of $28.25, indicating a potential upside of 7.74%. Strata Critical Medical has a consensus price target of $8.00, indicating a potential upside of 47.87%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Lindblad Expeditions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lindblad Expeditions	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Lindblad Expeditions has a beta of 2.22, indicating that its stock price is 122% more volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.22, indicating that its stock price is 122% more volatile than the broader market.

Summary

Lindblad Expeditions beats Strata Critical Medical on 9 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Genesis Energy?

Genesis Energy (NYSE:GEL) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

66.8% of Genesis Energy shares are owned by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are owned by institutional investors. 0.7% of Genesis Energy shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Genesis Energy presently has a consensus target price of $19.00, indicating a potential upside of 33.81%. Strata Critical Medical has a consensus target price of $8.00, indicating a potential upside of 47.87%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Genesis Energy.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genesis Energy	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Strata Critical Medical has a net margin of 20.56% compared to Genesis Energy's net margin of 2.11%. Genesis Energy's return on equity of 23.65% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genesis Energy	2.11%	23.65%	0.73%
Strata Critical Medical	20.56%	-4.06%	-3.49%

In the previous week, Genesis Energy had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 2 mentions for Genesis Energy and 0 mentions for Strata Critical Medical. Genesis Energy's average media sentiment score of 0.89 beat Strata Critical Medical's score of -0.05 indicating that Genesis Energy is being referred to more favorably in the media.

Company	Overall Sentiment
Genesis Energy	Positive
Strata Critical Medical	Neutral

Genesis Energy has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.22, meaning that its share price is 122% more volatile than the broader market.

Strata Critical Medical has lower revenue, but higher earnings than Genesis Energy. Genesis Energy is trading at a lower price-to-earnings ratio than Strata Critical Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genesis Energy	$1.63B	1.07	-$440.40M	-$0.19	N/A
Strata Critical Medical	$197.14M	2.37	$41.35M	-$0.08	N/A

Summary

Strata Critical Medical beats Genesis Energy on 10 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Costamare?

Strata Critical Medical (NASDAQ:SRTA) and Costamare (NYSE:CMRE) are both small-cap transportation companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Costamare has a net margin of 39.93% compared to Strata Critical Medical's net margin of 20.56%. Costamare's return on equity of 16.42% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	20.56%	-4.06%	-3.49%
Costamare	39.93%	16.42%	9.07%

In the previous week, Costamare had 6 more articles in the media than Strata Critical Medical. MarketBeat recorded 6 mentions for Costamare and 0 mentions for Strata Critical Medical. Costamare's average media sentiment score of 0.29 beat Strata Critical Medical's score of -0.05 indicating that Costamare is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
Costamare	Neutral

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 58.1% of Costamare shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Comparatively, 23.2% of Costamare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Strata Critical Medical has a beta of 2.22, indicating that its stock price is 122% more volatile than the broader market. Comparatively, Costamare has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

Strata Critical Medical presently has a consensus price target of $8.00, indicating a potential upside of 47.87%. Costamare has a consensus price target of $12.00, indicating a potential downside of 15.77%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Costamare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Costamare	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Costamare has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Costamare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.37	$41.35M	-$0.08	N/A
Costamare	$866.09M	1.98	$364.58M	$2.68	5.32

Summary

Costamare beats Strata Critical Medical on 11 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Flex LNG?

Strata Critical Medical (NASDAQ:SRTA) and Flex LNG (NYSE:FLNG) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Strata Critical Medical has a beta of 2.22, suggesting that its share price is 122% more volatile than the broader market. Comparatively, Flex LNG has a beta of 0.2, suggesting that its share price is 80% less volatile than the broader market.

Flex LNG has a net margin of 22.26% compared to Strata Critical Medical's net margin of 20.56%. Flex LNG's return on equity of 12.15% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	20.56%	-4.06%	-3.49%
Flex LNG	22.26%	12.15%	3.37%

In the previous week, Flex LNG had 1 more articles in the media than Strata Critical Medical. MarketBeat recorded 1 mentions for Flex LNG and 0 mentions for Strata Critical Medical. Flex LNG's average media sentiment score of 0.09 beat Strata Critical Medical's score of -0.05 indicating that Flex LNG is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
Flex LNG	Neutral

47.4% of Strata Critical Medical shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Comparatively, 0.3% of Flex LNG shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Flex LNG has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Flex LNG, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.37	$41.35M	-$0.08	N/A
Flex LNG	$347.64M	4.56	$74.82M	$1.40	20.92

Strata Critical Medical currently has a consensus target price of $8.00, indicating a potential upside of 47.87%. Flex LNG has a consensus target price of $24.00, indicating a potential downside of 18.04%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Flex LNG.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Flex LNG	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Flex LNG beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTA vs. The Competition

Export

Metric	Strata Critical Medical	Air Transportation Industry	Transportation Sector	NASDAQ Exchange
Market Cap	$468.11M	$1.03B	$8.75B	$12.48B
Dividend Yield	N/A	N/A	974.11%	6.51%
P/E Ratio	-67.63	10.65	24.88	24.70
Price / Sales	2.37	1.41	4.64	99.06
Price / Cash	N/A	2.32	8.32	57.09
Price / Book	1.68	5.10	2.26	6.46
Net Income	$41.35M	$125.56M	$531.96M	$337.01M
7 Day Performance	2.08%	-4.26%	0.02%	1.69%
1 Month Performance	-6.56%	-13.32%	-1.26%	3.81%
1 Year Performance	N/A	N/A	24.69%	23.90%

Strata Critical Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTA Strata Critical Medical	1.9838 of 5 stars	$5.41 flat	$8.00 +47.9%	N/A	$468.11M	$197.14M	N/A	130
ULCC Frontier Group	1.1507 of 5 stars	$7.73 -2.3%	$6.50 -15.9%	+83.1%	$1.78B	$3.72B	N/A	7,750	Gap Up
LIND Lindblad Expeditions	2.1904 of 5 stars	$26.77 -5.2%	$28.25 +5.5%	+105.0%	$1.75B	$771.02M	N/A	1,550	News Coverage Gap Up
GEL Genesis Energy	3.695 of 5 stars	$14.13 -0.3%	$19.00 +34.5%	-18.7%	$1.73B	$1.63B	N/A	1,061
CMRE Costamare	2.9637 of 5 stars	$14.03 +0.1%	$12.00 -14.5%	+53.3%	$1.69B	$877.90M	5.24	2,870	Dividend Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTA) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Critical Medical (SRTA) Competitors

SRTA vs. ULCC, LIND, GEL, CMRE, and FLNG

How does Strata Critical Medical compare to Frontier Group?

Summary

How does Strata Critical Medical compare to Lindblad Expeditions?

Summary

How does Strata Critical Medical compare to Genesis Energy?

Summary

How does Strata Critical Medical compare to Costamare?

Summary

How does Strata Critical Medical compare to Flex LNG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Critical Medical (SRTA) Competitors

SRTA vs. ULCC, LIND, GEL, CMRE, and FLNG

How does Strata Critical Medical compare to Frontier Group?

Is SRTA or ULCC more profitable?

Does the media refer more to SRTA or ULCC?

Which has preferable valuation & earnings, SRTA or ULCC?

Which has more volatility and risk, SRTA or ULCC?

Do institutionals & insiders hold more shares of SRTA or ULCC?

Do analysts recommend SRTA or ULCC?

Summary

How does Strata Critical Medical compare to Lindblad Expeditions?

Do institutionals and insiders hold more shares of LIND or SRTA?

Which has better valuation & earnings, LIND or SRTA?

Is LIND or SRTA more profitable?

Does the media prefer LIND or SRTA?

Do analysts rate LIND or SRTA?

Which has more risk and volatility, LIND or SRTA?

Summary

How does Strata Critical Medical compare to Genesis Energy?

Do insiders & institutionals have more ownership in GEL or SRTA?

Do analysts prefer GEL or SRTA?

Is GEL or SRTA more profitable?

Does the media prefer GEL or SRTA?

Which has more volatility and risk, GEL or SRTA?

Which has higher earnings and valuation, GEL or SRTA?

Summary

How does Strata Critical Medical compare to Costamare?

Is SRTA or CMRE more profitable?

Does the media refer more to SRTA or CMRE?

Do insiders and institutionals believe in SRTA or CMRE?

Which has more risk & volatility, SRTA or CMRE?

Do analysts prefer SRTA or CMRE?

Which has better earnings and valuation, SRTA or CMRE?

Summary

How does Strata Critical Medical compare to Flex LNG?

Which has more risk & volatility, SRTA or FLNG?

Is SRTA or FLNG more profitable?

Does the media favor SRTA or FLNG?

Do insiders & institutionals believe in SRTA or FLNG?

Which has better valuation & earnings, SRTA or FLNG?

Do analysts recommend SRTA or FLNG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools